Unite DE Gestion DES Projets (ugp) Pharmaceutical Import Profile — Cameroon (DGFT 2022–2026)

Name: Unite DE Gestion DES Projets (ugp) Pharmaceutical Import Records from India — 2 Products, $200.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unite DE Gestion DES Projets (ugp) — Pharmaceutical Importer Profile (2026) | 2 Products, $200.0K Trade | TransData Nexus

Unite DE Gestion DES Projets (ugp)

Pharmaceutical Importer · Cameroon · Antimalarial & Antiparasitic Focus · $200.0K Total Trade · DGFT Verified

Unite DE Gestion DES Projets (ugp) is a pharmaceutical importer based in Cameroon with a total trade value of $200.0K across 2 products in 1 therapeutic categories. Based on 4 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Unite DE Gestion DES Projets (ugp) sources from 4 verified Indian suppliers, with Mylan Laboratories Limited accounting for 48.8% of imports.

Unite DE Gestion DES Projets (ugp) — Import Portfolio & Supplier Network

Unite DE Gestion DES Projets (ugp) import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Unite DE Gestion DES Projets (ugp)?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mylan Laboratories Limited	$119.7K	5	48.8%
Macleods Pharmaceuticals Limited	$54.0K	2	22.0%
Sun Pharmaceutical Industries Limited

What Formulations Does Unite DE Gestion DES Projets (ugp) Import?

Formulation	Value	Ships
Dlt dolutegravir lamivudine and tenofovir disoproxil fumarate TAB 50 300 300mgeach TAB contains dolutegravir 50MG	$50.0K	1
Anzavir-ratazanavir 300MG + ritonavir	$50.0K	1
Sofosbuvir 400MG + daclatasvir 60MG	$50.0K	1
Drugs and pharmaceuticals harmless medicines abacavir and lamivudine tablets 600 300 MG bch no 14242673a mfg dt 10 24	$32.8K	1
Abacavir as sulfate and lamivudine dispersible tablets 120 MG 60 MG 8400 Pack Pack size 1 x 30	$21.7K	1
Drugs and pharmaceuticals harmless medicines dolutegravir sodium 10MG dispersible tablets for oral suspension bch no	$21.3K	1
Lamivudine 150MG + zidovudine 300MG TAB	$11.6K	1
Lamivudine 30MG zidovudine 60MG dispersible tablets 60 s no carton 3872 packs 60 s	$6.5K	1
Darunavir 600MG tablets 60 s durart600 40 packs 60 s	$1.7K	1
I we undertake to abide by the provisions of foreign exchange management act	$0	1
Gstin no 23aaacc1450b1zm lut no ad230325024901i dt 27 03	$0	1
As amended from time to time including realisation repatriation of foreignexchange to or from	$0	1
Pbw warehouse code bom1r067 address m scipla ltd c o s k logistics city link warehousing complex buliding no b	$0	1
Gala no 7a 8 9 10 11 survey no 121 10a 121 10b 69 village vadape bhiwandi	$0	1
Remitter stichting iplussolutions	$0	1

Unite DE Gestion DES Projets (ugp) imports 15 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pyrimethamine	Antimalarial & Antiparasitic	$100.0K	2	0.2%	9
2	Sulfadoxine	Antimalarial & Antiparasitic	$100.0K	2	0.2%	8

Unite DE Gestion DES Projets (ugp) imports 2 pharmaceutical products across 1 categories into Cameroon totaling $200.0K.

Unite DE Gestion DES Projets (ugp) — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Unite DE Gestion DES Projets (UGP) is a pharmaceutical importer based in Cameroon, specializing in the procurement of finished pharmaceutical formulations. The company plays a pivotal role in the distribution of essential medications within the Cameroonian healthcare system. UGP's operations are characterized by a focused import strategy, primarily sourcing antimalarial and antiparasitic drugs from India. This strategic sourcing aligns with Cameroon's public health priorities, particularly in combating malaria, a prevalent health concern in the region.

2Distribution Network

While specific details about UGP's warehouse locations and logistics capabilities are not publicly disclosed, the company's import activities suggest a well-established distribution network within Cameroon. The importation of pharmaceutical products, including antimalarial and antiparasitic medications, indicates that UGP has the necessary infrastructure to handle, store, and distribute these products effectively. Given the critical nature of these medications, it is reasonable to infer that UGP's logistics operations are designed to ensure timely and efficient delivery to various healthcare facilities across the country.

3Industry Role

UGP functions as a primary wholesaler in Cameroon's pharmaceutical supply chain. By importing finished pharmaceutical formulations, the company bridges the gap between international manufacturers and local healthcare providers. This role is crucial in ensuring the availability of essential medications, particularly antimalarial and antiparasitic drugs, which are vital for public health in Cameroon. UGP's operations support the government's efforts to provide accessible and effective healthcare solutions to its population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Unite DE Gestion DES Projets (ugp)

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

UGP's sourcing strategy exhibits a high degree of concentration, with a total import value of $200,000 USD from India, distributed across four shipments. The top five products imported—Pyrimethamine and Sulfadoxine—account for 100% of the import value, indicating a focused product portfolio. This concentration suggests a strategic choice to specialize in antimalarial and antiparasitic medications, aligning with the pressing health needs in Cameroon. However, such dependency on a limited number of products and suppliers could pose risks, including supply chain disruptions or price fluctuations. The stability of UGP's relationships with its Indian suppliers, such as MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and CIPLA LIMITED, is crucial to mitigate these risks.

2Supply Chain Resilience

UGP's supply chain resilience appears robust, given its partnerships with multiple reputable Indian pharmaceutical manufacturers. The diversity in suppliers—MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and CIPLA LIMITED—provides a level of redundancy, reducing the risk of total supply disruption. The importation of 15 unique formulations indicates a diversified product range within the antimalarial and antiparasitic categories. While specific details about shipping routes and regulatory compliance are not available, the involvement of established suppliers suggests adherence to international quality standards. Nonetheless, UGP's reliance on a single therapeutic category could limit its ability to adapt to changing market demands or health crises.

Importing Pharmaceuticals into Cameroon — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Cameroon

1Regulatory Authority & Framework

In Cameroon, the regulation of pharmaceutical products is overseen by the Ministry of Public Health (MINSANTE). The legal framework governing pharmaceutical imports includes Law No. 96/03 of 4 January 1996, which establishes a framework law in the field of health, and Decree No. 98/405/PM of 22 October 1998, which lays down the conditions and procedures for placing pharmaceutical products on the market. These regulations ensure that imported pharmaceutical products meet the required safety, efficacy, and quality standards before they are distributed within the country. Additionally, Cameroon is a member of the World Health Organization (WHO) and adheres to international standards for pharmaceutical regulation.

2Import Licensing & GMP

Cameroon does not operate an import licensing system for pharmaceutical products. However, the importation of medicines requires prior authorization from the Ministry of Public Health, specifically the Visa Transit Health of the Regional Delegation of Public Health. This authorization ensures that imported pharmaceutical products comply with national health regulations. Regarding Good Manufacturing Practice (GMP), Cameroon recognizes certifications from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers like UGP must ensure that their suppliers hold valid GMP certifications to guarantee the quality and safety of the pharmaceutical products they import.

Unite DE Gestion DES Projets (ugp) — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

UGP's focus on importing antimalarial and antiparasitic medications aligns with the significant public health need in Cameroon, where malaria remains a leading cause of morbidity and mortality. The importation of these specific therapeutic areas indicates a strategic decision to address critical health challenges. The market demand for these medications is driven by the high prevalence of malaria and other parasitic diseases in the region, necessitating a consistent and reliable supply of effective treatments. By concentrating on these areas, UGP positions itself as a key player in the fight against these diseases in Cameroon.

2Sourcing Profile

UGP's sourcing strategy is centered on importing generic antimalarial and antiparasitic formulations from India. This approach leverages India's established pharmaceutical manufacturing capabilities and cost-effectiveness. The focus on finished pharmaceutical formulations allows UGP to provide ready-to-use medications, ensuring timely availability in the Cameroonian market. By sourcing from India, UGP benefits from a diverse range of products and formulations, enhancing its ability to meet the specific needs of the local healthcare system.

3Market Positioning

Seller's Guide — How to Become a Supplier to Unite DE Gestion DES Projets (ugp)

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with UGP, given the company's focused import strategy and the ongoing demand for antimalarial and antiparasitic medications in Cameroon. Potential gaps in UGP's current sourcing include the need for a broader range of formulations or alternative suppliers to mitigate risks associated with supply chain disruptions. New suppliers can explore these opportunities by offering high-quality products that meet Cameroonian regulatory standards and by establishing reliable supply chains to ensure consistent delivery.

2Requirements & Qualifications

Indian exporters seeking to supply UGP and the broader Cameroonian market must ensure that their pharmaceutical products comply with international quality standards, including EU GMP, WHO GMP, and PIC/S certifications. Additionally, products must meet Cameroonian labeling requirements, including expiry dates and instructions for use in English and French. Exporters should also be prepared to obtain prior authorization from the Ministry of Public Health for their products and ensure that all packaging bears appropriate markings identifying the country of origin.

How to Approach

Frequently Asked Questions — Unite DE Gestion DES Projets (ugp)

What products does Unite DE Gestion DES Projets (ugp) import from India?

Unite DE Gestion DES Projets (ugp) imports 2 pharmaceutical products across 1 categories. Top imports: Pyrimethamine ($100.0K), Sulfadoxine ($100.0K).

Who supplies pharmaceuticals to Unite DE Gestion DES Projets (ugp) from India?

Unite DE Gestion DES Projets (ugp) sources from 4 verified Indian suppliers. The primary supplier is Mylan Laboratories Limited (48.8% of imports, $119.7K).

What is Unite DE Gestion DES Projets (ugp)'s total pharmaceutical import value?

Unite DE Gestion DES Projets (ugp)'s total pharmaceutical import value from India is $200.0K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Unite DE Gestion DES Projets (ugp) focus on?

Unite DE Gestion DES Projets (ugp) imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Unite DE Gestion DES Projets (ugp) Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.